Home | About CDC | Press Room | Funding | A-Z Index | Centers, Institute & Offices | Training & Employment | Contact Us
CDC Centers for Disease Control and Prevention Home Page
horizontal line  
Search: 
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
Malaria
Malaria Home > Interactive Training > Case Study 1 >
Case Study 1, Question 1: Correct Answer

Plasmodium vivax

This is the most probable diagnosis. The reported microscopic findings are compatible with P. vivax: some infected red cells are enlarged and deformed, and the "other forms with four nuclei" are compatible with the presence of schizonts. Plasmodium vivax does occur in Pakistan, where it is found in slightly more than 50% of malaria cases.

The history suggests a relapse of P. vivax malaria, following an earlier episode five weeks ago. The earlier treatment apparently did not include primaquine, thus allowing the persistence of hypnozoites which caused this relapse.

An alternate explanation would be that the earlier infection was caused by chloroquine-resistant P. vivax (which has been reported in Pakistan), with recrudescence of blood-stage parasites occurring after an unsuccessful earlier treatment (if indeed the earlier treatment included chloroquine). However, recrudescences usually occur within 28 days of the intial episode, rather than at five weeks as described here.

The other species are less likely:

  • While P. falciparum does occur in Pakistan (slightly less than 50% of malaria cases), this patient reportedly did not develop symptoms until 10 months after departure from the exposure area: most cases of P. falciparum would have become symptomatic earlier
  • P. ovale occurs mainly in Africa and has been found only occasionally in Asia (in the western Pacific)
  • P. malariae occurs worldwide, but its distribution is spotty, and its frequency in Pakistan is low to negligible. The diagnosis of P. malariae made during the earlier episode is not consistent with the current microscopic findings: red cells infected with P. malariae would not be enlarged and deformed, as described here.
  • Babesia would not fit with the microscopic description; in addition, babesiosis has not been reported in Pakistan, although admittedly the disease might have escaped detection

 

Page last modified : April 23, 2004
Content source: Division of Parasitic Diseases
National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ZVED)

 

horizontal line
Topic Contents
 arrow Topic Home
  arrow About Malaria
  arrow Biology
  arrow CDC Activities
  arrow Control and Prevention
  arrow Diagnosis and Treatment
  arrow Disease
  arrow Epidemiology
  arrow Geographic Distribution
  arrow History
  arrow Impact
  arrow References and Resources
  arrow Training
  arrow Travel
  arrow What's New
horizontal line
blackdots

Contact Info

Health Care Professionals
Health care providers needing assistance with diagnosis or management of suspected cases of malaria should call the CDC Malaria Hotline: 770-488-7788 (M-F, 8am-4:30pm, eastern time). Emergency consultation after hours, call: 770-488-7100 and request to speak with a CDC Malaria Branch clinician.

By email
blackdots
Fighting Malaria: CDC's Historic Commitment
Learn about malaria history…
blackdots
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
 Safer, Healthier People  USAGovDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435